Treatment of Major Depression

OBJECTIVE: The risk-benefit profile of antidepressant medications in bipolar disorder is controversial. When conclusive evidence is lacking, expert consensus can guide treatment decisions. The International Society for Bipolar Disorders (ISBD) convened a task force to seek consensus recommendations on the use of antid…

No abstract yet.

• HÜSEYİN AVNİ UYDU

No abstract yet.

• MUSTAFA BİLİCİ

BACKGROUND: Some, although not all, studies report small hippocampal volume in patients with major depressive disorder (MDD) relative to healthy controls. Here, we explore the contribution of key demographic and clinical variables to this difference. METHODS: We used meta-analytic techniques to provide an updated anal…

No abstract yet.

• MEHMET ERDAL VARDAR
• OKAN ÇALIYURT

BACKGROUND: We present recommendations for revision of the diagnostic criteria for the Dissociative Disorders (DDs) for DSM-5. The periodic revision of the DSM provides an opportunity to revisit the assumptions underlying specific diagnoses and the empirical support, or lack of it, for the defining diagnostic criteria…

• VEDAT ŞAR

The specific associations between antidepressant treatment and alterations in the levels of cytokines remain to be elucidated. In this study, we aimed to explore the role of IL-2, IL-4, IL-12, TNF-alpha, TGF-beta1, and MCP-1 in major depression and to investigate the effects of sertraline therapy. Cytokine and chemoki…

• SELİM YAVUZ SANİSOĞLU

No abstract yet.

• MEHMET HAKAN TÜRKÇAPAR

No abstract yet.

• ŞEFİK KAAN YÜCEL

OBJECTIVE: Some evidence indicates that an immune response with an increased production of proinflammatory cytokines often accompanies major depression. The objective of this study was to examine the serum levels of IL-6 in patients with major depression and the changes occurring in IL-6 levels during treatment with s…

• MAKBULE ÇİĞDEM AYDEMİR

BACKGROUND: In treatment-resistant depression, commonly defined as a lack of response to two or more consecutive treatments during the current depressive episode, the percentage of patients with remission is low and the percentage with relapse is high. The efficacy and safety of esketamine nasal spray as compared with…

• MEMDUHA AYDIN

No abstract yet.